These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 22276575)

  • 21. Early-onset lichenoid graft-vs.-host disease: a unique variant of acute graft-vs.-host disease occurring in peripheral blood stem cell transplant recipients.
    Magro CM; Kerns MJ; Votava H; Vasil KE; Dyrsen ME; Morrison CD
    J Cutan Pathol; 2010 May; 37(5):549-58. PubMed ID: 19843195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The skin manifestation of acute graft-versus-host disease: clinical and pathological analysis.
    Hsu ML; Chen YC; Wu YC; Chen CL; Yeh HP; Hsieh KH; Lu YC
    Taiwan Yi Xue Hui Za Zhi; 1989 Jul; 88(7):657-62. PubMed ID: 2809558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD123 is a useful immunohistochemical marker to facilitate diagnosis of acute graft-versus-host disease in colon.
    Lin J; Chen S; Zhao Z; Cummings OW; Fan R
    Hum Pathol; 2013 Oct; 44(10):2075-80. PubMed ID: 23791208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of graft-versus-host disease on skin endothelial and epithelial cell chimerism in stem-cell transplant recipients.
    Willemze AJ; Bakker AC; von dem Borne PA; Bajema IM; Vossen JM
    Transplantation; 2009 Apr; 87(7):1096-101. PubMed ID: 19352133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Macrophage migratory inhibitory factor (MIF) expression in acute graft-versus-host disease (GVHD) in allogeneic hemopoietic stem cell transplant recipients.
    Lo JW; Leung AY; Huang XR; Lie AK; Metz C; Bucala R; Liang R; Lan HY
    Bone Marrow Transplant; 2002 Sep; 30(6):375-80. PubMed ID: 12235522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Significance of mucosal vs salivary gland changes in lip biopsies in the diagnosis of chronic graft-vs-host disease.
    Nakhleh RE; Miller W; Snover DC
    Arch Pathol Lab Med; 1989 Aug; 113(8):932-4. PubMed ID: 2757495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A method for modeling skin explants--an in vitro predictive test for graft vs host disease in allogenic hematopoietic cell transplantation].
    Hromadníková I; Sedlácek P; Starý J; Vavrinec J; Cermáková-Frantlová M; Stechová K; Houbová B; Vítek A; Sajdová J; Sviland L; Dickinson AM
    Cas Lek Cesk; 2001 Feb; 140(3):73-8. PubMed ID: 11284422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Skin biopsy in diagnosis of chronic graft-versus-host disease in patients after allogeneic haematopoietic stem cell transplantation: pathologist's point of view on quantitative scoring system].
    Grzanka D; Styczyński J; Debski R; Krenska A; Pacholska M; Prokurat AI; Wysocki M; Marszałek A
    Med Wieku Rozwoj; 2008; 12(4 Pt 2):1105-11. PubMed ID: 19531834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclosporin A-induced graft-versus-host disease following autologous bone marrow and stem cell transplantation in hematological malignancies of childhood.
    Gruhn B; Häfer R; Kosmehl H; Fuchs D; Zintl F
    Bone Marrow Transplant; 1998 May; 21(9):901-7. PubMed ID: 9613782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of skin histology in GVHD after intestinal transplantation.
    Pintar T; Zorc-Pleskovic R; Alessiani M; Milutinović A; Pleskovic A
    Eur J Pediatr Surg; 2007 Dec; 17(6):412-5. PubMed ID: 18072027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic mucosal changes of the colon in graft-versus-host disease.
    Asplund S; Gramlich TL
    Mod Pathol; 1998 Jun; 11(6):513-5. PubMed ID: 9647587
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Unrelated donor stem cell transplantation in children: low toxicity using a GvHD-prophylaxis regimen with CSA, MTX, metronidazole,iv-immunoglobulin and ATG].
    Graf Finckenstein F; Zabelina T; Dürken M; Dahlke J; Kröger N; Krüger W; Janka-Schaub G; Erttmann R; Zander AR; Kabisch H
    Klin Padiatr; 2002; 214(4):206-11. PubMed ID: 12165903
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosis of gastrointestinal graft-versus-host disease--is rectal biopsy enough?
    Nydegger A; Catto-Smith AG; Tiedemann K; Hardikar W
    Pediatr Blood Cancer; 2007 May; 48(5):561-6. PubMed ID: 16862539
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia].
    Liu QF; Sun J; Zhang Y; Liu XL; Xu D; Xu B; Feng R; Meng FY; Zhou SY
    Ai Zheng; 2004 Apr; 23(4):426-9. PubMed ID: 15087032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment costs and survival in patients with grades III-IV acute graft-versus-host disease after allogenic hematopoietic stem cell transplantation during three decades.
    Svahn BM; Ringdén O; Remberger M
    Transplantation; 2006 Jun; 81(11):1600-3. PubMed ID: 16770251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized trial of high dose polyvalent intravenous immunoglobulin (HDIgG) vs. Cytomegalovirus (CMV) hyperimmune IgG in allogeneic hemopoietic stem cell transplants (HSCT).
    Zikos P; Van Lint MT; Lamparelli T; Gualandi F; Occhini D; Mordini N; Berisso G; Bregante S; Bacigalupo A
    Haematologica; 1998 Feb; 83(2):132-7. PubMed ID: 9549924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation between the kinetics of CD3+ chimerism and the incidence of graft-versus-host disease in patients undergoing allogeneic hematopoietic stem cell transplantation.
    Rupa-Matysek J; Lewandowski K; Nowak W; Sawiński K; Gil L; Komarnicki M
    Transplant Proc; 2011 Jun; 43(5):1915-23. PubMed ID: 21693300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human leucocyte antigen-identical haematopoietic stem cell transplantation in major histocompatiblity complex class II immunodeficiency: reduced survival correlates with an increased incidence of acute graft-versus-host disease and pre-existing viral infections.
    Renella R; Picard C; Neven B; Ouachée-Chardin M; Casanova JL; Le Deist F; Cavazzana-Calvo M; Blanche S; Fischer A
    Br J Haematol; 2006 Sep; 134(5):510-6. PubMed ID: 16848795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of acute and chronic graft-versus-host disease on normal and malignant B-lymphoid precursors after allogeneic stem cell transplantation for B-lineage acute lymphoblastic leukemia.
    Sánchez-García J; Serrano J; Gómez P; Martínez F; Martín C; Román-Gómez J; Rodríguez A; Herrera C; García JM; Alvarez MA; Torres A
    Haematologica; 2006 Mar; 91(3):340-7. PubMed ID: 16531257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Skin explant model of human graft-versus-host disease: prediction of clinical outcome and correlation with biological risk factors.
    Wang XN; Collin M; Sviland L; Marshall S; Jackson G; Schulz U; Holler E; Karrer S; Greinix H; Elahi F; Hromadnikova I; Dickinson AM
    Biol Blood Marrow Transplant; 2006 Feb; 12(2):152-9. PubMed ID: 16443513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.